CCL2 and ischemia: It was found that administration of the epithelium-derived exosomal ATF3 (activating transcription factor 3) mRNA attenuates ischemia/reperfusion-induced kidney injury by inhibiting monocyte chemotactic protein-1 (MCP-1)-induced macrophage infiltration (Chen et al., 2014b).